Alisa Lee Sherick MD
Though pediatric cancer survival rates have considerably improved over the past 40 years, childhood acute myeloid leukemia (AML) is still has a relatively poor outcome. This is partially because the immune system has a hard time recognizing and killing AML cells. Dr. Lee Sherick’s lab has found that when a protein called MerTK is present […]
Mirian Rosenberg, PhD
Muller Fabbri, MD, PhD
Dr. Fabbri’s proposed research project focuses developing an effective but less toxic mechanism for treating Neuroblastoma. It is known that Neuroblastoma can be effectively treated with a type of cell in a person’s body called a Natural Killer Cell. However, Natural Killer Cell therapy is extremely toxic and often must be stopped before a patient […]
Theodore Nicolaides, MD
At University of California San Francisco, Dr. Nicolaides is developing treatments for children with glioma brain tumors. A new drug shown to be successful against this tumor has also shown to be very susceptible to resistance in certain patients. Understanding how that resistance develops can result in more effective drugs, and ultimately save lives.
Austin Brown, PhD
Cognitive deficits are a known effect of treatment for brain tumors in children. But not all children with brain tumors are affected by treatment equally. At Houston’s Baylor College of Medicine, Dr. Brown is focused on genetic markers, and their ability to predict which kids will be most adversely affected by treatment. Such findings could […]
Gregory J. Aune, MD, PhD
Dr. Gregory John Aune is a Stephanie Edlund Distinguished Professor in Pediatric Cancer Research. He earned his Ph.D. and M.D. from University of Texas Health Science Center. Personal and professional experiences in pediatric cancer fueled his interest in childhood cancer. He is a long-term survivor of Hodgkin’s lymphoma. What is Dr. Aune currently researching? Pre-clinical […]